Frazier Lifesciences Acquisition Corp

Frazier Lifesciences Acquisition Corp, trading under the ticker FLAC, is a blank-check company sponsored by Frazier Healthcare Partners, a Seattle-based investment firm with a long track record in the life sciences and healthcare sector. FLAC completed its initial public offering in 2021 and focuses its acquisition search on biopharmaceutical, medical device, diagnostics, and related life sciences businesses. The company filed a Form 10-Q with the SEC on August 11, 2022, reflecting its continued status as a pre-combination SPAC at that time. Frazier Healthcare Partners brings deep domain expertise to the sponsor role, having backed numerous healthcare companies across venture and growth stages. Visit SpacDesk and sign up for full data on FLAC, including deal timelines, SEC filings, and sponsor history.